Pérez-Eslava EML, Vizzuette-Mendoza EG

Language: Spanish
References: 17
Page: 225-229
PDF size: 38.32 Kb.

ABSTRACT

Purposes: To compare the ocular hypontensor effect of latanoprost, travoprost and bimatoprost in patients with ocular hypertension (OH) and open angle primary glaucoma (OAPG). To evaluate the intraocular tension variations during the day and the main adverses effects of these drugs.
Patients and methods: A experimental, longitudinal, prospective, comparative and blind evaluator study was done. Three patients groups were organized, with latanoprost (0.005%), travoprost (0.004%) and bimatoprost (0.03%) application respectively. The intraocular pressure (IOP) and the adverses effects of the drugs were evaluated the day 0 (base), week 1, 4, 8 and 12 of treatment.
Results: Eigthteen patients were studied (36 eyes). In all of them the intraocular tension was more of 30% less in comparison with the initial measure and had a significative level (p=0.03). The more common adverse effect was the conjuntival hiperemy.
There were not important intraocular pressure variations during the day.
Conclusions: There was average IOP significative diminution respect to the base in the three study groups. Bimatoprost diminished the IOP 40.5% in comparison with 34.8% y 36.7% for latanoprost and travoprost respectively.

REFERENCES

1. Netland PA, Landry T, Sullivan EK. Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 132(4):472-84.

2. Stamper RL. Mecanismos del daño al nervio óptico en glaucoma. Highlights Opthalmology 2002; 30(1): 5-7.

3. Alward WL. Glaucoma, Los requisitos en oftalmología. México, Harcourt, 2001.

4. Cantar L, Berlin MS, Hodapp EA y cols. Glaucoma basic and clinical science course. Chicago, American Academy of Ophthalmology, 1999.

5. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991; 11(1):51-5.

6. The AGIS Investigators. The advanced glaucoma intervention study (AGIS) 7: The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130:429-440.

7. Parrish RK, Palmberg P, Scheuw P, XLT Study Group. A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator, multicenter study. Am J Ophthalmol 2003; 135:688-703.

8. Shields BM. Glaucoma. 2a ed. Buenos Aires, Panamericana, 1987.

9. Bonomi L, Marchini G, Marrafa M y cols. Prevalence of glaucoma and intraocular pressure distribution in a defined population. Ophthalmology 1998; 105 (2):209-215.

10. Noecker RS, Dirks MS, Choplin NT y cols. Estudio clínico de seis meses de duración, comparando la eficacia para disminuir la presión intraocular de bimatoprost y latanoprost en pacientes con hipertensión ocular o glaucoma. Am J Ophthalmology 2003; 135:55-63.

11. Arruda PA. Glaucoma. Principios generales diagnóstico y tratamiento. Quito, Ciba Visión, 1999.

12. Asrani S, Zeimer R, Wilensky J, Gieser D y cols. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000; 9(2):134-42.

13. Drance SM. Diurnal variation of intraocular pressure in treated glaucoma: significance in patients with chronic simple glaucoma. Arch Ophthalmol 1963; 70:302-311.

14. Drance SM. The significance of the diurnal tension variation in normal and glaucomatous eyes. Arch Ophthalmol 1960; 64:494-501.

15. Realini T, Barber L, Burton D. Frecuency of asymmetric intraocular pressure fluctuations among patients with and without glaucoma. Ophthalmology 2002; 109(7):1367-1371.

16. Netland PA, Allen RC. Glaucoma medical therapy principles and management. Chicago, American Academy of Ophtalmology, 1999.

17. Perry CM, Mc Gavin JK, Culy CR y cols. Latanoprost, una actualización de su uso en glaucoma y en hipertensión ocular. Drugs Aging 2003; 20 (8):597-626.